Senate LDA lobbying filing

Pfizer, Inc.

A public disclosure record: who filed, what they reported, and the program connections found in the text.

Reported amounts Program mentions Activity text Lobbyists

Registrant: AVOQ, LLC Year: 2024 Period: First Quarter Type: 1A

Filed as: PFIZER, INC. — AVOQ, LLC. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

$50.0K

Reported expenses

not reported

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
General health issues; H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act; H.R. 7174, To amend title XI of the…

Lobbying activities3

Health IssuesHCR
General health issues; H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act; H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
Taxation/Internal Revenue CodeTAX
Issues related to the Vaccine Injury Compensation Program
Trade (domestic/foreign)TRD
Issues related to a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 therapeutics

Lobbyists3

BILL GHENT
SANDRA ALCALA
STEVEN ELMENDORF

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.